SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lazarus Long who wrote (2225)6/30/1998 7:44:00 PM
From: Gwolf  Read Replies (1) of 5402
 
Everyone should do their own evaluation on this stock, no two people look at a stock the same way. There are hundreds of books on stock market evaluation, some use a dividend discount model, price to sales, P.E. as a percentage of earnings growth and so on and so forth. This stock can only be based on an 'Anticipated Market Value for the Product'.

I would encourage everyone to do their own evaluations and not depend on anyone else's valuations. I hope you all noticed that I never placed an actual value on the stock when I gave you the type of criteria that analyst use, that was because it was a guideline that you could fit your own numbers into. Do your own DD own this stock, you should be buying it based on what you think it is worth and not what somebody else thinks it's worth and that includes me. That's right ignore me and go do your own homework - it's your money.

Gwolf
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News